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ABSTRACT: The treatment of hydrocephalus has undergone remarkable transformation 
since it was first documented over two thousand years ago. Currently, the focus of 
hydrocephalus research is on minimally invasive techniques of treatment.  This article 
reviews the evolution of hydrocephalus therapy, and examines current attitudes towards 
modern methods. We relied on journal publications, as well as literature on hydrocephalus 
obtained from the Internet (Google, Yahoo and PUBMED search) making use of the 
following search terms: “hydrocephalus: history; treatment; complications”, “cerebrospinal 
fluid shunt”, “endoscopic third ventriculostomy: indications of; complications of; 
advantages; disadvantages; successes; failure”. Numerous medical and surgical approaches 
have been adopted in the treatment of hydrocephalus in the past. However, the 
breakthrough that ushered in the modern era of hydrocephalus treatment was the 
introduction of valve-regulated systems in the middle of the last century. Endoscopic third 
ventriculostomy has evolved to become an alternative to traditional shunts. Cerebrospinal 
fluid shunt procedures are very effective in the treatment of hydrocephalus and have 
radically transformed the outcome of the disorder. However, they have a number of 
limitations. The alternative to shunts, endoscopic third ventriculostomy, is relatively safe, 
effective and durable. It does not, however, succeed in every patient; and also has some 
potentially devastating complications. Preoperative counseling is imperative to ensure that 
patients are properly guided. 
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INTRODUCTION
Ψ 
 
Hydrocephalus is a clinical entity characterised by 
excess accumulation of cerebrospinal fluid (CSF) 
in the ventricles and subarachnoid pathways, 
usually as a result of disturbance in its formation, 
flow or absorption. The term “hydrocephalus” itself 
is derived from the Greek words hydro (water) and 
cephali (head)
1. 
Hippocrates (5
th century B.C.), widely regarded as 
the father of medicine, is credited to be the first to 
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document hydrocephalus, the treatment of which he 
reportedly attempted by ventricular punctures
2,3. 
Since then, treatment of the condition has 
undergone remarkable transformation, partly 
because of the increased understanding of the 
anatomy and physiology of the ventricular system 
and CSF pathways, recent technological advances 
with accompanying improved instrumentation, and 
the discovery of biocompatible materials in the last 
century. Thus, many of the erstwhile methods of 
treatment which were either unsuccessful or fraught 
with complications have been replaced by modern 
management techniques. 
An increasing number of neurosurgeons are keying 
into the new treatments. Similarly, with the 
increased volume of information available to 
patients, an increasing number of them now also 
specifically request for some of the modern Eghwrudjakpor et al / Surgical interventions for hydrocephalus 
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methods as against traditional means of CSF 
diversion.   
This paper examines some of the major landmarks 
in the evolution of hydrocephalus therapy, and 
highlights the role of patient selection and 
appropriate training of practitioners of modern 
methods in ensuring optimal results and prevention 
of some of the potentially devastating 
complications. 
 
EVOLUTION OF INTERVENTIONS FOR 
HYDROCEPHALUS 
 
Cases of hydrocephalus were described by Galen 
(130 – 200 A.D.), who thought that the disorder 
was a result of extra-axial accumulation of water 
rather than enlargement of the ventricles – an 
impression that led to countless errors in diagnosis 
and treatment
4,5. 
Early and medieval Arabian physicians also 
described the condition. Prominent among these 
was Abul-Qasim Al-Zahrawi who, in a 30-volume 
treatise on medicine, dealt with various aspects of 
neurosurgery, including the diagnosis and treatment 
of hydrocephalus. He was the first to describe in 
detail the evacuation of superficial intracranial fluid 
in hydrocephalic children
4,6. 
Vesalius (1514 – 1564), an Italian physician, 
clarified several aspects of the anatomical and 
pathological characteristics of hydrocephalus, 
pointing out that in one of his patients, “the ‘water’ 
had not collected between the brain and its 
surrounding membrane, but within the ventricles of 
the brain”. He also thought that the CSF was a 
vaporous substance, the “spiritus animalis,” which 
was produced in the ventricles and provided energy 
and motion to all parts of the body
6-8. 
Thomas Willis in 1664, suggested that the choroid 
plexus was responsible for the production of CSF, 
contrary to the popular opinion at the time, which 
also held that the ventricles contained a vapor 
during life and which, after death, condensed and 
gravitated to the spaces in and around the brain and 
spinal cord. Robert Whytt, in the mid 18
th century 
was, however, the first to depict hydrocephalus as a 
disease. He described several cases which were 
associated with tuberculous meningitis which he 
ascribed as cause of the condition
7. 
With the advancements in the understanding of the 
physiology and anatomy of the ventricular system 
and cerebrospinal fluid in the 19
th century
8, the 
stage was set for the entrance of modern shunting 
techniques. In 1825, Magendie described the 
circulation of CSF within the brain (which was 
later named the “third circulation” by Cushing), 
and identified the midline foramen of the fourth 
ventricle. This was followed, three and half 
decades later, by the description of two additional 
lateral outlet foramina by Luschka. The detailed 
description of the meninges, the subarachnoid 
spaces (including the basal cisterns), the ventricles 
and the arachnoid villi by Key and Retzius in their 
anatomical atlas was another major milestone
7. 
 
Treatments 
 
Before the late 19th century, treatment of 
hydrocephalus was more conservative than active 
intervention
9. The early attempts in treatment were 
mostly unsuccessful owing to poor understanding 
of the pathophysiology of the condition. Cures 
were thought to be rare and treatments fraught with 
complications. 
Some of the therapeutic measures that were applied 
include: intraventricular injection of iodine, head 
wrapping, carotid artery ligation and phlebotomy. 
Other reported attempts at medical cures included 
the use of thyroid extract, dyes, diuretics and 
purgatives such as rhubarb, jalap and calomel. 
Most of these failed and it became obvious that the 
hydrocephalus was primarily a disease best treated 
surgically, although it was without definitive 
cure
10. 
Reports on many of the early surgical interventions 
in the literature were neither clear nor could they be 
substantiated by sufficient evidence
4. In 1891, 
Quincke described lumbar puncture as an effective 
treatment for hydrocephalus
8,10 while Keen was 
credited with the first description of continuous 
ventricular drainage
10,11. 
What may be regarded as one of the important 
forerunners of modern day shunts was credited to 
Mikulicz who in 1893 attempted the first 
permanent shunt by draining CSF from the lateral 
ventricle to the subarachnoid, subdural and 
subgaleal spaces using gold tubes and cat-gut 
strands
4,10,12. 
In 1908, the “Balkenstich Method”, a procedure 
involving perforation of the corpus callosum with 
drainage of CSF into the subdural spaces was 
introduced by the German surgeons, Anton and von 
Bramann. The procedure, however, remained 
unpopular because of the low cure rates and high 
mortality associated with it
13. 
Other approaches that were attempted by different 
workers include: drainage of the CSF from the 
temporal horn of the lateral ventricle into the cheek 
fat pad, and drainage through the roof of the orbit 
(ventriculo-orbitotomy). But neither of these met 
with significant success
10. 
Payr, also in 1908, introduced shunting of CSF 
from the ventricle into the sagittal sinus and jugular 
veins using vein grafts
14; and in the same year, 
Kausch used a rubber conduit to drain the lateral 
ventricle into the peritoneal cavity. Unfortunately, 
this did not initially attract much interest
9,10,15. 
Heile, at about this time, attempted to divert CSF 
from the spinal canal to the peritoneal cavity by 
various techniques including suturing of the gut 
serosa to the dura mater and the use of conduits like Eghwrudjakpor et al / Surgical interventions for hydrocephalus 
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veins and latex tubes. He was also credited with the 
first attempt to divert CSF to the urinary system
16. 
Matson and his colleagues also reported diverting 
CSF to the urinary system from the ventricles and 
lumbar subarachnoid space; but their technique 
required the performance of nephrectomy, and was 
associated with several complications like fluid and 
electrolyte disorders and infections
12,17,18.  Cushing 
also attempted to divert CSF from the spinal 
subarachnoid space to the peritoneal cavity or 
retroperitoneum with silver cannulae passed 
through apertures in the L-4 vertebral body
8,10. 
Several other workers attempted to bypass 
obstructions within the ventricular system by 
various methods. Dandy was however, credited 
with the introduction of third ventriculostomy to 
bypass aqueductal stenosis
10,12,19 - the technique 
being later refined by Stookey and Scarff 
7,10,12,20. 
Torkildsen, diverted CSF by passing a shunt from 
the lateral ventricle to the cisterna magna 
(ventriculocisternostomy). Even though this 
technique was initially successful, its acceptance 
was limited by the postoperative morbidity which 
was also considerable
21. 
Other workers also attempted diversion of CSF to 
different sites such as the heart, jugular vein, 
pleural cavity, thoracic duct, gallbladder, ileum, 
fallopian tube and salivary ducts
10. Over time, 
however, the right atrium and peritoneal cavity 
became the choice destinations for CSF diversion. 
However, the breakthrough that ushered in the 
modern era of hydrocephalus surgery was the 
introduction of valves and flow-regulated shunt 
systems, and biocompatible synthetic materials in 
the middle of the 20
th century
10. This development 
enhanced the safe and reliable diversion of CSF 
devoid of many of the complications of unregulated 
CSF drainage that preceded it
10,12,22,23. 
Since then, there have been remarkable 
improvements both in the surgical techniques and 
in the properties of the shunt devices themselves. 
Numerous systems are currently available; each 
with some modification designed to improve 
performance, enhance safety or prevent known 
complications. More recently, devices with 
programmable valves for fine-tuning CSF flow 
rates were also introduced
9. 
Before the era of modern shunting techniques and 
more sophisticated hardware however, children 
with hydrocephalus generally had a poor prognosis, 
and majority of them were not offered surgical 
intervention. Among untreated cases, only about 
20% reached adulthood, with the survivors having 
a 50% chance of living with permanent brain 
damage. Currently, most children with 
hydrocephalus reach adulthood with proper shunt 
management; and studies show that over 50% of 
these are educable
1. 
The effectiveness of shunts is high
24; and shunting 
procedures have thus become standard treatment 
for most types of hydrocephalus, having radically 
transformed the outcome of the disorder. 
In spite of the impressive advances in shunt 
techniques, hardware properties, diagnostics and 
follow-up however, shunts still have inherent 
tendencies for complications, such as malfunction 
and infection
25,26; with more than 10% of 
ventriculoperitoneal shunts having to be revised at 
some point for various reasons (such as growth of 
the child, mechanical obstruction of the device, 
infection, etc)
27. In addition, the reported long-term 
shunt-related mortality rate of shunt-treated 
patients remains high (2.9% to 12.4% at 10 years 
follow-up)
28. 
An often ignored aspect in the follow-up of shunt-
treated patients is the psychological burden of 
having to live with a foreign body (both on the 
patients themselves and on their families). Clinical 
data show that this could be quite profound. 
Eghwrudjakpor and Essien reported the case of a 
near disastrous alteration in family 
psychodynamics resulting from the placement of a 
ventriculoperitoneal shunt in one of their 
hydrocephalic patients
29,30. 
With the limitations of shunts in the treatment of 
hydrocephalus becoming more obvious, it became 
necessary to seek plausible alternative methods of 
treatment of the condition. Currently, the focus of 
hydrocephalus research is on, among others, 
minimally invasive techniques of treatment of the 
condition
2. 
 
ENDOSCOPIC THIRD 
VENTRICULOSTOMY 
 
One of the significant advances in the modern 
treatment of hydrocephalus has been the evolution 
of endoscopy. Its re-entry in neurosurgery in the 
1980s and 1990s
31 was partly prompted by the need 
for precise placement of ventricular catheters. With 
technological advancements and the miniaturisation 
of equipment accompanying it, it is now possible to 
carry out actions at the level of the floor of the third 
ventricle. This has brought about a renewal of 
interest in endoscopic third ventriculostomy (ETV) 
as an alternative treatment for obstructive 
hydrocephalus
25,26,29.32. 
Endoscopic third ventriculostomy, by allowing 
drainage of cerebrospinal fluid from the ventricles 
directly into the subarachnoid space
27, re-
establishes a physiological route of CSF dynamics. 
It is not, however, an entirely novel concept. At the 
beginning of the 20th century, attempts were made 
to introduce scopes into the ventricular system and 
remove the choroid plexus
2. 
Before the advent of modern valve-regulated shunt 
systems, third ventriculostomy through open 
craniotomy (which was described by Dandy in 
1922
33), was the main treatment modality for 
hydrocephalus. The procedure, however, fell out of Eghwrudjakpor et al / Surgical interventions for hydrocephalus 
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favour because of the high morbidity and mortality 
associated with it. 
Endoscopic third ventriculostomy (ETV) was 
performed by William Mixter in 1923 with the aid 
of a urethroscope which he used to examine and 
perform the procedure in a child with obstructive 
hydrocephalus
34,35. Twenty years later, McNickle 
introduced a percutaneous method of performing 
the procedure. This resulted in a reduction in the 
rate of complications while bringing about 
significant improvement in the success rate
36. Other 
developments closely followed with the 
introduction of the leucotome, stereotactic frame, 
etc
37. 
Currently, ETV is much more refined and is 
relatively common practice; and has become the 
treatment of choice in patients (especially adults) 
with acquired or late-onset occlusive 
hydrocephalus in many tertiary care neurosurgical 
centres
4,24. 
 
Indications for endoscopic third ventriculostomy 
 
ETV was initially performed as a bypass procedure 
for the treatment of hydrocephalus in patients with 
aqueductal stenosis (AS)
38; and currently, AS is 
still one of the major indications for it. 
Nevertheless, several workers think that ETV 
should not be used to treat AS because the 
subarachnoid space in many of these patients is not 
sufficiently developed
34,39. 
The list of reported indications for the procedure 
includes a wide range of unrelated disorders, all of 
which have hydrocephalus as the common 
denominator. They include Dandy-Walker 
malformation, idiopathic stenosis of the fourth 
ventricular outlet foramina of Magendie and 
Luschka, pineal and tectal tumours, hydrocephalus 
due to intraventricular haematoma or that due to the 
mass effect caused by intraventricular tumours, 
posterior fossa tumours; and suprasellar arachnoid 
cysts. ETV may also have a role in the management 
of hydrocephalus associated with Chiari 
malformation, long standing overt 
ventriculomegaly (LOVA), persistent shunt 
infection, and intraventricular haemorrhage (IVH) 
that are resistant to regular shunting techniques. 
ETV is also thought to be effective in many cases 
of "slit-ventricle" syndrome as a means of getting 
the patients to become shunt-independent. In the 
latter case, it is first necessary to first exteriorise 
the shunt in order to control CSF drainage until an 
adequate working diameter of the ventricles is 
achieved
28,38,40-52. 
 
Patient selection 
 
Despite the resurgence of interest in ETV, not 
every hydrocephalic patient benefits from the 
procedure; with wide variation in the success rates 
being reported by different series. This variation is 
thought to be partly due to differences in the 
criteria used for selecting patients
26 and differences 
in technique. Patient selection thus has a very 
important role in determining the overall success 
rate of the procedure. At present, however, there 
are no common criteria for patient selection
24; but 
clinical evidence shows that certain features 
increase the probability of success (which is 
defined by shunt independence)
27,38. These include: 
1.  The presence of obstructive hydrocephalus. 
ETV has the highest chance of being 
successful in patients with pure obstruction of 
CSF flow within the ventricular system. 
Preoperative Magnetic Resonance Imaging 
(MRI) is particularly useful in this respect 
because it can clearly demonstrate any existing 
blockade. ETV has also been performed in 
patients with non-obstructive hydrocephalus. 
The long-term effectiveness of this indication 
is however not known. 
2.  Age of patient above one year. There are few 
studies which indicate the effectiveness of 
ETV in infants. Clinical data, however, suggest 
that the overall success rate in newborn infants 
is not as high as in older age groups
53. It is 
thought that this may be because the child’s 
brain is still developing and the pressure 
generated within it during this period is no 
enough to keep the third ventriculostomy 
patent. 
3.  Onset of hydrocephalus should be relatively 
recent. The chances of success appear to be 
highest among adult patients in this group. 
4.  There should be no intracranial infection or 
subarachnoid haemorrhage. 
5.  The ventricles should be dilated. This would 
afford easier access of the instruments to the 
floor of the third ventricle. 
6.  Ventricular anatomy should be normal. 
It is opined that the decision to perform ETV 
should preferably be taken jointly with the patient 
or his family after proper counseling
27. It is 
important that they be made to understand the 
limitations of the procedure; and be prepared to 
have a regular shunt inserted should the ETV fail. 
 
Advantages of endoscopic third ventriculostomy 
 
Endoscopic third ventriculostomy has several 
advantages over traditional shunts. These have 
contributed to a large extent to its appeal among 
neurosurgeons, patients and their families alike. 
1.  In the first place, the procedure, when 
successful, eliminates the dependence on 
mechanical shunt devices with all their 
limitations; while normalising CSF dynamics 
in patients with obstructive hydrocephalus. 
With the absence of foreign object implanted 
in the body, the risk of infection is Eghwrudjakpor et al / Surgical interventions for hydrocephalus 
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significantly reduced
29; and there is no risk of 
tissue reaction. 
2.  The duration of surgery is comparatively 
shorter; which means that the patient is 
subjected to less anaesthesia. 
3.  The success rate is high among appropriately 
selected patients. 
4.  Fewer incisions are needed to perform an ETV. 
5.  The procedure itself is elegant, relatively low-
risk and its performance is comparatively 
simple. 
6.  The problem of CSF over-drainage (with the 
attendant complications such as slit ventricle 
syndrome) is completely eliminated. 
7.  The long term complication rate of ETV is less 
compared to regular shunts. Revisions are also 
rare. However, some patients need shunt 
placement to improve despite a patent 
ventriculostomy
24. 
8.  Revision of ETV is relatively infrequent.  
 
Complications of endoscopic third 
ventriculostomy 
 
Even though endoscopic third ventriculostomy has 
been greatly refined, especially in recent years, the 
procedure is not without complications. Though 
they are much fewer, some of the reported 
complications are quite serious. 
In a series of 339 paediatric patients who 
underwent ETV for hydrocephalus, Beems and 
Grotenhuis reported a complication rate of 7.7%
45, 
while Amini and Schmidt reported a complication 
rate of 14% in their series of 36 adult patients, even 
though none of the complications in the latter 
resulted in any permanent sequelae
38. 
One of the most serious complications of ETV is 
injury to the Basilar Artery complex or its 
perforating vessels, which can result in catastrophic 
haemorrhage or brainstem infarction
38. Others 
include bleeding at the level of the choroid plexus, 
ventricular wall, ventriculostomy, or 
interpeduncular cistern. Intraparenchymal or 
subdural hemorrhage and infection are less 
common complications
38,54,55. 
Some patients who have undergone ETV fail to 
improve despite a patent ventriculostomy; and 
many of these need to have regular shunting 
devices inserted
24. In some of these cases, a repeat 
ETV may be indicated. Such repeat procedures are 
usually effective and safe. But they have also 
sometimes been associated with complications such 
as convulsions, pulmonary oedema, raised 
intracranial pressure and cardiac arrhythmia
51. 
 
Success rates 
 
The reported success rate of ETV varies from 50 to 
94%. The success of ETV appears to depend on 
several factors, e.g. the technique used, the 
experience of the endoscopic neurosurgeon and, 
very importantly, the type of patients selected for 
the procedure
26,37,38,45,56,57. The chances of success 
appear to be highest among adult patients with 
recent-onset aqueductal stenosis (such as those with 
posterior fossa metastatic disease). The scoring 
system (the ETV success score), has been found to 
be very useful in predicting the probability of 
success of the procedure in the treatment of 
hydrocephalus  
 
Failure of endoscopic third ventriculostomy 
 
Despite the appeal and attractiveness of ETV, it is 
not always successful. It is essential that patients or 
their relatives be made aware of this fact before it is 
performed. The failure rate is thought to be highest 
in the first 2 to 3 months following the procedure. 
Clinical data show that if ETV does not fail during 
the first few months, the chances of it failing 
subsequently are considerably reduced
27,58, 
However, failures have also been reported years 
later. 
In their retrospective analysis carried out to 
determine the success or failure of endoscopic third 
ventriculostomy in 170 patients who underwent it 
as a primary procedure and 63 patients who 
underwent ETV as a secondary procedure for shunt 
malfunction, O’Brien et al reported that among the 
patients in whom the procedure failed in both 
groups, more than 95% were evident within 1 
month of the procedure
58. 
One of the commonest causes of failure of ETV is 
the presence of Liliequist's membrane which may 
obstruct the outflow of cerebrospinal fluid from the 
fenestration made in the floor of the third 
ventricle
59. In their series of 36 adult patients who 
underwent ETV, Amini et al found that 22% in 
whom the procedure was initially successful later 
had closure of the fenestration with recurrence of 
symptoms at a mean interval of 3.75 years
38. 
A number of other factors predispose to failure of 
ETV probably by obliterating the cerebrospinal 
fluid (CSF) pathways. Some of the better known 
ones include intraventricular haemorrhage, 
tuberculous meningitis, repeated shunt infections 
and Chiari I malformation.   
 
Patient follow-up post ETV 
 
Thus, in patients who undergo this treatment, long-
term periodic follow-up review should be carried 
out so as to detect problems early. This is 
particularly important during the first few months, 
because studies show that the chance of blockage 
of the fenestration is most likely at this time. 
Failure to recognise and promptly treat this 
complication could be disastrous
38. It is important 
that patients and their families are properly 
informed that the procedure is not a cure for Eghwrudjakpor et al / Surgical interventions for hydrocephalus 
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hydrocephalus. They should also be made aware of 
the possibility of shunt insertion should the need 
arise. 
 
THE FUTURE OF ETV 
 
Due to the attractiveness and elegance of ETV, 
more neurosurgeons now perform the procedure 
and the number is expected to grow. In view of the 
obvious advantages, more and more patients and 
their families now also specifically request for it as 
an alternative to traditional shunts. The number of 
such requests is likely to escalate with increase in 
the amount of information available to patients. It 
is of utmost importance, therefore, that 
neurosurgeons be properly informed so as to give 
appropriate counseling to patients to enable them 
make informed choices. 
Even though the techniques of endoscopic third 
ventriculostomy have continued to improve, 
neurosurgeon should also always bear in mind that 
the seemingly simple procedure holds the potential 
for very serious complications. Thus, there is need 
for appropriate training of endoscopic 
neurosurgeons in order to prevent avoidable 
complications, and ensure the best results in 
operated cases. It is imperative, therefore, that 
surgeons continue to report their experience with 
the complications of ETV so that the procedure can 
continue to be made as safe as possible
60. 
 
CONCLUSION 
 
The ultimate goal in the treatment of patients with 
hydrocephalus is to get them to be shunt-free
28. 
Endoscopic third ventriculostomy offers this 
chance. 
The procedure affords a safe, effective and durable 
method of treatment for hydrocephalus, especially 
in older children and adults (including those with 
chronic compensated hydrocephalus and brainstem 
tumours)
38.  The overall outcome depends on the 
cause of the disorder. 
It is important that preoperatively, there should be 
adequate counselling of patient and family about all 
aspects of the procedure, including risks, successes, 
possibility of failure and the long-term 
complications. 
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